ISRAEL EGERUO: Open Payments
NPI 1083489835 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 51 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $373 |
| ABBVIE INC. | 14 | $321 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $284 |
| Neurocrine BioSciences, Inc. | 4 | $98 |
| Alkermes, Inc. | 3 | $44 |
| Lundbeck LLC | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: REXULTI, VRAYLAR, CAPLYTA, INGREZZA, ARISTADA, COBENFY, FANAPT.
Industry payments across MA — which companies pay providers there.
